Mettler-Toledo Lifts EPS Outlook Amid Tariff Drag
Mettler-toledo International ((MTD)) has held its Q1 earnings call. Read on for the main highlights of the call.
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Mettler-Toledo International’s latest earnings call struck a cautiously upbeat tone, with management balancing solid growth and raised profit guidance against clear macro and tariff headwinds. Executives stressed resilient demand in key regions, strong service momentum and innovation-led share gains, while acknowledging softer organic trends in certain lab and European chemical markets.
Revenue Growth and Acquisitions Drive Top Line
Mettler-Toledo reported Q1 sales of $947 million, with local-currency revenue up 3% and U.S. dollar sales up 7%. Acquisitions were an important contributor, adding roughly 1.5% to growth and helping offset weaker organic demand in some mature end markets.
Adjusted EPS Up 9% and Profitability Holds
Adjusted EPS climbed 9% year over year to $8.91, while adjusted operating profit rose 4% to $246 million. The adjusted operating margin came in at 26%, down 80 basis points on a reported basis but up about 40 basis points after stripping out currency impacts.
Full-Year EPS Outlook Raised
Management raised its full-year adjusted EPS range to $46.30–$46.95, implying 8%–10% growth versus last year. The upgrade from a prior 8%–9% growth view reflects confidence in execution, easing comparisons and a healthier demand pipeline into the back half.
Service Growth and Capital-Return Commitment
Service revenue grew 7% in Q1, or 5% when excluding acquisitions, underscoring the durability of this recurring stream. The company reiterated its free cash flow goal of about $900 million in 2026 and plans robust share repurchases of $825 million–$875 million this year.
China and Emerging Markets Support Growth
Asia and the rest of world delivered 5% local-currency growth, including a 4% gain in China. Mettler-Toledo raised its full-year China growth expectation to the mid-single digits, while emerging markets such as India and Southeast Asia continued to post very strong results.
Industrial and Product Inspection Strength
Industrial sales rose 5% in local currency, with core industrial up 1% and product inspection surging 11%. Strong innovation and a targeted mid-market strategy helped product inspection win share, making it a standout growth engine in the portfolio.
Innovation Pipeline and New Product Launches
The company kept its R&D investment growing, spending $51 million in local currency, up 1% from a year ago. New launches ranged from the EasyMax automated lab reactor and InMotion PX One autosampler to PFAS-free pipette tips and more sensitive M50 R-Series X-ray inspection systems.
Tariff and FX Treatment Embedded in Outlook
Guidance now explicitly incorporates tariff and foreign-exchange assumptions, with FX at recent spot rates expected to add about 2% to sales and be neutral to EPS. Management is also excluding any potential tariff refunds from adjusted EPS and from its organic sales growth calculations.
Margins Pressured by Tariff Headwinds
Gross margin slipped to 58.7%, an 80-basis-point decline versus last year, largely due to higher tariffs. Management estimated an incremental gross tariff headwind of about 90 basis points, translating into roughly a 4% drag on operating profit and on EPS.
Soft Organic Growth and Customer Caution
Organic sales growth excluding acquisitions was just 1% in Q1, showing modest underlying momentum. Management cited customer delays and increased caution in Western markets, linked to geopolitical uncertainties that are affecting near-term order timing.
Lab Segment Dragged by Pipettes and Academia
The laboratory business delivered local-currency growth of 1% but was flat without acquisitions, reflecting uneven demand. Pipette sales declined as academic and some biotech customers remained under pressure, creating a notable headwind for overall lab performance.
European Chemical and Process Analytics Weakness
European chemical markets softened, hurt by elevated energy costs and subdued investment. This weighed on the Process Analytics division and parts of the lab business, creating a regional drag even as other geographies showed healthier trends.
Free Cash Flow Hit by Tax Timing
Adjusted free cash flow was $120 million in the quarter, held back by $58 million of higher tax payments versus a year ago. Management also pointed to timing differences on certain grants, including a China-related grant, which skewed the quarterly cash-flow profile.
Reported EPS Distorted by Non-Operating Charges
Reported EPS came in at $8.33, below the adjusted figure due to several non-operating items. These included purchased-intangible amortization, restructuring costs and a small timing headwind from stock-option exercises, which together reduced the headline result.
Retail Business Volatility in the Americas
Food retail revenue grew 7% overall, but performance was uneven, with U.S. retail down double digits in the quarter. Strength in European retail helped offset this decline, while management reminded investors that this business is inherently lumpy and can skew quarterly pacing.
Guidance Signals Steady Growth and Discipline Ahead
For 2026, Mettler-Toledo expects about 4% local-currency sales growth with acquisitions adding less than 1% for the full year, and adjusted EPS of $46.30–$46.95, up 8%–10%. Q2 guidance calls for roughly 3% local-currency growth and 6%–8% EPS growth, with FX slightly helping sales but remaining neutral to earnings.
Mettler-Toledo’s call highlighted a business navigating macro and tariff crosscurrents while still delivering profit growth and returning significant cash to shareholders. With improving trends in China, strong service and industrial franchises, and a disciplined outlook, management’s tone remained net positive, albeit with clear awareness of regional and segment-specific risks.
